IM NEUENHEIMER FELD 584, HEIDELBERG, GERMANY, 69120
国家
CH
上市日期
2026-06-11
财年截止
十二月
流通股数
1.41亿
CIK
--
官方网址
--
Veraxa Biotech AG 是一家创新型生物技术公司,致力于开发变革性治疗方案,以满足关键的医疗需求。通过利用先进的生物技术平台,Veraxa 正在推进一系列有前景的新型候选药物,覆盖多个治疗领域。公司致力于科学卓越,其战略愿景聚焦于创建专有技术,旨在提供突破性疗法,从而提升全球患者护理水平。随着其推进关键临床开发阶段,Veraxa 在战略上已做好准备,以吸引合作伙伴关系和投资,从而在不断发展的生物技术行业中推动自身增长。
财务指标
--
常见问题
VRXA is the ticker symbol for a publicly traded company listed on a U.S. stock exchange. The stock represents an ownership stake in that company, giving investors a claim on its future earnings and assets. To identify the exact company behind VRXA, review the profile section on this page, which provides the company name, business description, and listing details.
Recent performance of VRXA can be seen in the price chart and performance summary displayed on this page, which typically shows daily, weekly, and year-to-date changes. Because stock prices fluctuate continuously during market hours, the latest VRXA price and performance figures should be checked directly on the page rather than relying on any static description.
Valuation for VRXA can be assessed using metrics such as the price-to-earnings ratio, price-to-sales ratio, price-to-book ratio, and enterprise value multiples, depending on the company's industry and profitability. These figures should be compared with peers and the company's own historical averages. The latest valuation metrics for VRXA are available on this page, and investors should use those current numbers when analyzing the stock.
VRXA may be eligible for pre-market and after-hours trading through certain brokerage platforms, depending on the exchange listing and the broker's rules. Extended-hours sessions usually have lower liquidity, wider spreads, and higher volatility than regular trading hours. Whether VRXA specifically supports extended-hours trading can be confirmed with a broker or by checking the trading details shown on this page.
Analyzing VRXA's financial performance involves reviewing its income statement, balance sheet, and cash flow statement, along with metrics such as revenue growth, gross margin, operating margin, net income, and free cash flow. Trends across multiple quarters or years help show whether the business is improving or deteriorating. The latest reported financials and earnings data for VRXA are available on this page.
Risks for VRXA can include business-specific challenges such as competition, customer concentration, or execution problems, as well as broader market risks like economic downturns, interest rate changes, and sector rotation. Volatility, liquidity, and financial leverage may also affect the stock. Reviewing VRXA's risk factors in its SEC filings and the company profile on this page can help investors understand the key exposures.